Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
about
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of ViewRecurrence and Treatment after Renal Transplantation in Children with FSGSCirculating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed CandidatesUpdate on the treatment of focal segmental glomerulosclerosis in renal transplantationPodocytesA circulating permeability factor in focal segmental glomerulosclerosis: the hunt continuesPrinciples of separation: indications and therapeutic targets for plasma exchange.De novo glomerular diseases after renal transplantationIssues in solid-organ transplantation in children: translational research from bench to bedside.Glomerular diseases: FSGS.Pathogenesis of Focal Segmental GlomerulosclerosisCitral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in miceGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An UpdateBone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosisSerum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGSDefining nephrotic syndrome from an integrative genomics perspective.Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injuryMinimal change disease as a modifiable podocyte paracrine disorder.Nephrotic syndrome in children: from bench to treatmentEthanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE.Treatment of steroid-resistant pediatric nephrotic syndrome.Focal segmental glomerulosclerosis: molecular genetics and targeted therapiesEfficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.Complement Activation in Patients with Focal Segmental Glomerulosclerosis.Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.Circulating suPAR in two cohorts of primary FSGS.Renal cortical hemopexin accumulation in response to acute kidney injury.Remission of secondary membranous nephropathy in a patient with Kimura disease after surgical resectionThe plasma permeability factor in nephrotic syndrome: indirect evidence in pediatric peritoneal dialysis.Recent progress in the pathophysiology and treatment of FSGS recurrence.Serum glomerular albumin permeability activity: association with rapid progression to end-stage renal disease in focal segmental glomerulosclerosis.Drug discovery in focal and segmental glomerulosclerosisPatients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational StudyTLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.
P2860
Q26738374-176B4CEE-ADE5-4F19-8817-6EAFDF0CEECCQ26746985-65A04146-FBC8-4EB7-9951-641AD4A36228Q26747221-DFCD6179-AA9C-4785-BD50-2A66A27D03B3Q26751470-9C3D3141-9987-4F94-858C-ECC227DA286AQ26766118-8F9D3D73-8675-47EA-80AB-79A8E7F0B77EQ26776389-CBC16F4A-D0BF-4DDF-A879-0BCB1E5D334CQ26830899-F0318519-83C0-4F51-A473-FCDCE1C495DFQ27005877-2B5EE4A3-6A57-4495-9794-149BE229BECEQ27023312-3381FDD5-134C-48D6-A5FA-285A06AD546AQ27687257-CF7FD91C-D977-4F74-B06C-5BC8971DEBD3Q28067299-0CE981B5-FBBE-4ED0-94CF-2D18B9FEED43Q28533529-45325FB8-B312-4EB9-9556-023AFB6087A5Q30276550-0885973A-52E8-460A-B748-9DAAE768FDCAQ33586501-C99E3D93-319B-43C8-81FF-A3B38E42632FQ33605113-5A6EE984-38EE-4552-A7A5-054869FFA7F8Q33783271-85B106C8-4930-4B58-8708-72302D5ABDFFQ33826145-70B32B43-E56F-4E2E-85A0-AEF7618347C8Q33872298-B93DE8FC-3EC9-491E-8AF1-22466F56CBBEQ34363025-EF6E377F-6E9E-4FF9-A30F-E7BBCC5965AFQ34455143-ED96CD9C-9C8E-4BF2-B749-A19822E549FDQ34560989-DC1069C4-0EC2-459A-8E80-477D8675CC48Q34787780-9FC750A5-6AC8-47BE-899A-AF52FB458DB0Q34805111-12345C97-C4A8-4482-8510-BA4F251F4859Q35133160-632A22DB-7EEA-4D54-AC57-321915886B37Q35185376-62A78EDD-D8D5-41BC-9C8F-FA75936BEE26Q35269800-086F49C5-F0E7-4FC9-965D-BA4AB2BAB198Q35540016-A7C64ED5-9215-41B9-8E98-4F795DD10F76Q35686453-28062904-8590-43FE-AD79-F2C16F90FE26Q35704498-2A9BF51B-37D0-4D48-A375-BAF71A7AD07DQ35763276-8A9A7B55-4120-4375-ADB5-470A4A45B5A1Q36003160-617D3CE1-A6DE-4398-A683-3E68CB83B0A8Q36426091-95CEB14D-5E53-45C7-B1FF-6C2B9E68BD2DQ36454161-6E0B4105-5833-4F13-82D0-5D25B5F3B605Q36466071-7C850381-9288-4D2A-8AB5-7C6E19F61858Q36474221-282D7208-C3A5-4CC8-8E73-F78FD0D40CDAQ36572659-2A01C971-0318-449F-9243-280372B49298Q36789030-98E6DDA3-E11C-4D88-97A7-CBD2AA642405Q36924116-0CEBD230-CADF-4ED2-962B-F1E28C1D55ACQ36992978-E3815659-DE29-46BB-843C-00FB440D9675Q37036149-C92CE0E4-A809-4E20-9F51-4FB5D1B6249D
P2860
Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating permeability facto ...... segmental glomerulosclerosis.
@en
Circulating permeability facto ...... segmental glomerulosclerosis.
@nl
type
label
Circulating permeability facto ...... segmental glomerulosclerosis.
@en
Circulating permeability facto ...... segmental glomerulosclerosis.
@nl
prefLabel
Circulating permeability facto ...... segmental glomerulosclerosis.
@en
Circulating permeability facto ...... segmental glomerulosclerosis.
@nl
P2093
P356
P1476
Circulating permeability facto ...... segmental glomerulosclerosis.
@en
P2093
Ellen T McCarthy
Mukut Sharma
Virginia J Savin
P304
P356
10.2215/CJN.03800609
P577
2010-10-21T00:00:00Z